

Cover Story
Guest Editorial
At a recent NIH study section that I chaired, we had many applications that we reviewed as a group before the meeting. At the meeting, we were required to discuss over 50% of the grants.
By Claire Dietz and Matthew Bin Han Ong
Conversation with The Cancer Letter
By Matthew Bin Han Ong and Claire Dietz
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for July
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”
- Surviving cancer is often not a patient’s most challenging battle
- The other side of the patient portal: Reflections from a cancer center leader
- We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James